In June 2019 the Argentinian Anti-Doping Commission has reported an anti-doping rule violation against the rugby player after his sample tested positive for the prohibited substance Betametasone. After notification the Athlete filed a statement in his defence and failed to attend the hearing of the National Disciplinary Anti-Doping Tribunal (TNDA).
The Athlete admitted the violation and denied the intentional use of the substance. He explained with evidence that as treatment for his asthma prescribed medication was used. He argued that he had mentioned his medication on the Doping Control Form whereas his application for a retroactive TUE was denied by the TUE Panel.
The Tribunal finds that the presence of a prohibited substance has been established in the Athlete’s sample and accordingly without a valid TUE he had committed an anti-doping rule violation.
The Tribunal accepts that the violation was not intentional and considers the Athlete’s degree of fault and negligence in this case. Further it holds that there were delays in the proceedings attributed to the Athlete. Therefore the TNDA decides on 13 March 2020 to impose a 2 year period of ineligibility on the Athlete.
